175 results on '"Cui, Xiuyu"'
Search Results
2. Enhancing insight into ferroptosis mechanisms in sepsis: A genomic and pharmacological approach integrating single-cell sequencing and Mendelian randomization
3. 891 Beta-adrenergic blockade licenses the use of immunotherapy in primary and metastatic brain tumors
4. IMMU-49. BETA-ADRENERGIC BLOCKADE LICENSES THE USE OF IMMUNOTHERAPY IN PRIMARY AND METASTATIC BRAIN TUMORS
5. Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors
6. Supplementary Figure 7 from T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma
7. Table S2 from A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma
8. Supplementary Figure 5 from T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma
9. Supplementary Figure 4 from T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma
10. Supplementary Figure 1 from T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma
11. Figure S1 from A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma
12. Supplementary Figure 2 from T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma
13. Supplementary Figure 6 from T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma
14. Supplementary Table 1 from T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma
15. Supplementary Figure 3 from T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma
16. A Novel MHC-Independent Mechanism of Tumor Cell Killing by CD8+T Cells
17. Flow Cytometric Identification of Tumor-Infiltrating Lymphocytes from Glioblastoma
18. Abstract 1378: CD8 T cell mediated killing of MHC class 1 negative tumors requires antigen presenting myeloid cells and interferon gamma
19. Synaptotagmin‐11 inhibits cytokine secretion and phagocytosis in microglia
20. CD8 T cells licensed with immune checkpoint blockade kill murine tumors lacking MHC-I
21. CD62L− memory T cells enhance T-cell regeneration after allogeneic stem cell transplantation by eliminating host resistance in mice
22. Vascular Endothelial Cells Produce Soluble Factors That Mediate the Recovery of Human Hematopoietic Stem Cells after Radiation Injury
23. Pathogenic Mutations Differentially Regulate Cell-to-Cell Transmission of α-Synuclein
24. Abstract A80: The effects of CCL3 on dendritic cell migration and immune cell activation
25. 4-1BB Agonism Averts TIL Exhaustion and Licenses PD-1 Blockade in Glioblastoma and Other Intracranial Cancers
26. Targeting PD-L1 Initiates Effective Antitumor Immunity in a Murine Model of Cushing Disease
27. Synaptotagmin‐11 regulates the functions of caveolae and responds to mechanical stimuli in astrocytes
28. Plasmonic gold nanostar-mediated photothermal immunotherapy for brain tumor ablation and immunologic memory
29. Phospholipase C and protein kinase A mediate bradykinin sensitization of TRPA1: a molecular mechanism of inflammatory pain
30. Hematopoietic stem cell dose correlates with the speed of immune reconstitution after stem cell transplantation
31. Transfer of allogeneic CD62L– memory T cells without graft-versus-host disease
32. Author Correction: Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors
33. Bone Marrow T-Cell Sequestration and Lymphopenia Accompanying Ischemic Stroke are Mediated by T-Cell S1P1 Loss
34. BSCI-03. T CELL EXHAUSTION SIGNATURES VARY BY TUMOR TYPE AND ARE INDEPENDENT OF INTRACRANIAL LOCATION
35. BSCI-07. BONE MARROW T-CELL SEQUESTRATION IN THE SETTING OF BRAIN METASTASES
36. IMMU-23. ANTIGEN-SPECIFIC EFFECTOR MEMORY CD4+ T CELLS AND CCL3 POTENTIATE DENDRITIC CELL VACCINES AND ANTITUMOR IMMUNITY
37. EXTH-23. A NOVEL NANOTECHNOLOGY-BASED PLATFORM IMPROVES LASER INTERSTITIAL THERMAL THERAPY FOR INTRACRANIAL TUMORS
38. IMMU-27. PREVENTING T-CELL S1P1 INTERNALIZATION OBVIATES BONE MARROW T CELL SEQUESTRATION AND IMPROVES IMMUNOTHERAPEUTIC EFFICACY IN GBM
39. T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma
40. Addition of a second, different allogeneic graft accelerates white cell and platelet engraftment after T-cell–depleted bone marrow transplantation
41. A comparison of murine T-cell–depleted adult bone marrow and full-term fetal blood cells in hematopoietic engraftment and immune reconstitution
42. Frequency-dependent ERK phosphorylation in spinal neurons by electric stimulation of the sciatic nerve and the role in electrophysiological activity
43. Synaptotagmin‐11 regulates the functions of caveolae and responds to mechanical stimuli in astrocytes.
44. A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma
45. TMOD-49. ANTITUMOR EFFICACY OF ANTI-PDL1 IN ACTH-SECRETING PITUITARY ADENOMAS: AN IMMUNOTHERAPEUTIC APPROACH FOR CUSHING’S DISEASE
46. IMST-08. EXPRESSION OF PDL-1 ON PITUITARY ADENOMAS: A ROLE FOR IMMUNOTHERAPY
47. IMST-11. DOWNREGULATION OF SPHINGOSINE-1-PHOSPHATE RECEPTOR TYPE 1 MEDIATES BONE MARROW T-CELL SEQUESTRATION IN PATIENTS AND MICE WITH GLIOBLASTOMA
48. IMST-32. T CELL EXHAUSTION IN PATIENTS AND MICE WITH GBM
49. Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
50. Novel role of hematopoietic stem cells in immunologic rejection of malignant gliomas
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.